RIT Biotech is an authorised seller of poisons (Pharmacy and Poisons Ordinance CAP.138, Certificate of registration of premises under section 13).
We are fully complied with the requirements provided under the conditions of the “Guidelines on Current Good Radiopharmacy Practice (cGRPP) in the Preparation of Radiopharmaceuticals” issued by the European Association of Nuclear Medicine.
That is the latest requirement requested by the Drug Office, Department of Health according to the licensing condition.
Besides, RIT Biotech and Molecular Imaging and Medical Cyclotron Centre (MIMCC), Department of Diagnostic Radiology, The University of Hong Kong are collaboration partners to provide PET products, such as 68Ga-PSMA and 68Ga-DOTATOC.
(Figure: RIT Biotech Company Limited - clean room environment that comply with cGMP, USP797, cGRPP and IAEA guidance)
